サマリー

卵管癌治療薬の世界市場 2022-2026 年
Technavioは卵管癌治療薬市場を監視しており、2022-2026年の間に62828万ドル、予測期間中にCAGR9.06%で加速して成長すると予測しています。当レポートでは、卵管癌治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、女性の健康に対する関心の高まり、強力な医薬品承認の数々、戦略的提携によって牽引されています。
卵管癌治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの卵管癌治療薬市場は、以下のように区分されています。
製品別
- 標的治療薬
- 化学療法
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間における卵管がん治療薬市場の成長を促進する主要な理由の一つとして、再生療法に関する研究の拡大を挙げています。また、がんの治療用ワクチンの登場や、効果的な治療のためのナノテクノロジーの利用が拡大していることも、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。卵管癌治療薬市場に関する当レポートは、以下の分野を対象としています。
- 卵管癌治療薬市場のサイジング
- 卵管癌治療薬市場の予測
- 卵管癌治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie社、Amgen社、Baxter International社、Bristol Myers Squibb社、Clovis Oncology社、Eli Lilly社、F. Hoffmann La Roche社、GlaxoSmithKline Plc社、ImmunoGen社、Johnson and Johnson社、Merck and Co.Inc.、ノバルティスAG。また、卵管癌治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/fallopian-tube-cancer-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Targeted therapy - Market size and forecast 2021-2026
o Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
o 5.4 Chemotherapy - Market size and forecast 2021-2026
o Exhibit 32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Austria - Market size and forecast 2021-2026
o Exhibit 62: Chart on Austria - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Austria - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Austria - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Austria - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Switzerland - Market size and forecast 2021-2026
o Exhibit 70: Chart on Switzerland - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Switzerland - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Switzerland - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Switzerland - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Amgen Inc.
o Exhibit 85: Amgen Inc. - Overview
o Exhibit 86: Amgen Inc. - Product / Service
o Exhibit 87: Amgen Inc. - Key offerings
o 10.4 Baxter International Inc.
o Exhibit 88: Baxter International Inc. - Overview
o Exhibit 89: Baxter International Inc. - Business segments
o Exhibit 90: Baxter International Inc. - Key news
o Exhibit 91: Baxter International Inc. - Key offerings
o Exhibit 92: Baxter International Inc. - Segment focus
o 10.5 Bristol Myers Squibb Co.
o Exhibit 93: Bristol Myers Squibb Co. - Overview
o Exhibit 94: Bristol Myers Squibb Co. - Product / Service
o Exhibit 95: Bristol Myers Squibb Co. - Key offerings
o 10.6 Clovis Oncology Inc.
o Exhibit 96: Clovis Oncology Inc. - Overview
o Exhibit 97: Clovis Oncology Inc. - Business segments
o Exhibit 98: Clovis Oncology Inc. - Key offerings
o Exhibit 99: Clovis Oncology Inc. - Segment focus
o 10.7 Eli Lilly and Co.
o Exhibit 100: Eli Lilly and Co. - Overview
o Exhibit 101: Eli Lilly and Co. - Product / Service
o Exhibit 102: Eli Lilly and Co. - Key offerings
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 103: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 104: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 105: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 106: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 107: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 GlaxoSmithKline Plc
o Exhibit 108: GlaxoSmithKline Plc - Overview
o Exhibit 109: GlaxoSmithKline Plc - Business segments
o Exhibit 110: GlaxoSmithKline Plc - Key news
o Exhibit 111: GlaxoSmithKline Plc - Key offerings
o Exhibit 112: GlaxoSmithKline Plc - Segment focus
o 10.10 ImmunoGen Inc.
o Exhibit 113: ImmunoGen Inc. - Overview
o Exhibit 114: ImmunoGen Inc. - Product / Service
o Exhibit 115: ImmunoGen Inc. - Key offerings
o 10.11 Johnson and Johnson
o Exhibit 116: Johnson and Johnson - Overview
o Exhibit 117: Johnson and Johnson - Business segments
o Exhibit 118: Johnson and Johnson - Key news
o Exhibit 119: Johnson and Johnson - Key offerings
o Exhibit 120: Johnson and Johnson - Segment focus
o 10.12 Merck and Co. Inc.
o Exhibit 121: Merck and Co. Inc. - Overview
o Exhibit 122: Merck and Co. Inc. - Business segments
o Exhibit 123: Merck and Co. Inc. - Key news
o Exhibit 124: Merck and Co. Inc. - Key offerings
o Exhibit 125: Merck and Co. Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Austria - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Austria - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Austria - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Austria - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Switzerland - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Switzerland - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Switzerland - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Switzerland - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Amgen Inc. - Overview
Exhibits86: Amgen Inc. - Product / Service
Exhibits87: Amgen Inc. - Key offerings
Exhibits88: Baxter International Inc. - Overview
Exhibits89: Baxter International Inc. - Business segments
Exhibits90: Baxter International Inc. - Key news
Exhibits91: Baxter International Inc. - Key offerings
Exhibits92: Baxter International Inc. - Segment focus
Exhibits93: Bristol Myers Squibb Co. - Overview
Exhibits94: Bristol Myers Squibb Co. - Product / Service
Exhibits95: Bristol Myers Squibb Co. - Key offerings
Exhibits96: Clovis Oncology Inc. - Overview
Exhibits97: Clovis Oncology Inc. - Business segments
Exhibits98: Clovis Oncology Inc. - Key offerings
Exhibits99: Clovis Oncology Inc. - Segment focus
Exhibits100: Eli Lilly and Co. - Overview
Exhibits101: Eli Lilly and Co. - Product / Service
Exhibits102: Eli Lilly and Co. - Key offerings
Exhibits103: F. Hoffmann La Roche Ltd. - Overview
Exhibits104: F. Hoffmann La Roche Ltd. - Business segments
Exhibits105: F. Hoffmann La Roche Ltd. - Key news
Exhibits106: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits107: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits108: GlaxoSmithKline Plc - Overview
Exhibits109: GlaxoSmithKline Plc - Business segments
Exhibits110: GlaxoSmithKline Plc - Key news
Exhibits111: GlaxoSmithKline Plc - Key offerings
Exhibits112: GlaxoSmithKline Plc - Segment focus
Exhibits113: ImmunoGen Inc. - Overview
Exhibits114: ImmunoGen Inc. - Product / Service
Exhibits115: ImmunoGen Inc. - Key offerings
Exhibits116: Johnson and Johnson - Overview
Exhibits117: Johnson and Johnson - Business segments
Exhibits118: Johnson and Johnson - Key news
Exhibits119: Johnson and Johnson - Key offerings
Exhibits120: Johnson and Johnson - Segment focus
Exhibits121: Merck and Co. Inc. - Overview
Exhibits122: Merck and Co. Inc. - Business segments
Exhibits123: Merck and Co. Inc. - Key news
Exhibits124: Merck and Co. Inc. - Key offerings
Exhibits125: Merck and Co. Inc. - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations